Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now

Page 5 of 12

8. Amgen Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders: 72

Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers, develops, manufactures, and markets human therapeutics. It delivers new therapies for patients with complex cancers, especially in areas with significant unmet needs. The company ranks eighth on our list of the top pharma stocks to invest in.

On May 1, Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amgen Inc. (NASDAQ:AMGN) and set a price target of $400.00, supported by its strategic positioning and strong financial performance. The company’s fiscal Q1 2025 results showed a notable EPS beat, supporting the buy rating and highlighting its cost management and operational efficiency, especially in R&D spending.

The analyst reasoned that management’s reiteration of its guidance for fiscal year 2025 highlights confidence in sustained profitability and revenue growth. Amgen Inc. (NASDAQ:AMGN) has a robust pipeline, especially in cardiovascular disease and obesity. When coupled with its strategic focus on biosimilars and legacy brands, the company’s overall outlook remains positive.

Page 5 of 12